INS and type 1 diabetes mellitus: This computer model of the human metabolic system simulates the glucose-insulin dynamics in T1D patients, and is approved by the US Food and Drug Administration (FDA) as an alternative for pre-clinical testing of insulin therapies, including closed-loop algorithms (22).